A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Targeting mitochondrial dysfunction with small molecules in intervertebral disc aging and degeneration
2021
GeroScience
AbstractThe prevalence of rheumatic and musculoskeletal diseases (RMDs) including osteoarthritis (OA) and low back pain (LBP) in aging societies present significant cost burdens to health and social care systems. Intervertebral disc (IVD) degeneration, which is characterized by disc dehydration, anatomical alterations, and extensive changes in extracellular matrix (ECM) composition, is an important contributor to LBP. IVD cell homeostasis can be disrupted by mitochondrial dysfunction.
doi:10.1007/s11357-021-00341-1
pmid:33634362
pmcid:PMC8110620
fatcat:ve25ccdkuzhgtcn4y4434nlfvu